Guidance

Survey: Veterinary Practices Are Uninformed About and Unprepared to Comply With New FDA Guidance Slated for October 1, 2022 Enforcement

Retrieved on: 
Tuesday, August 30, 2022
FDA, Health, Consumer, Pets, Pharmaceutical, Veterinary, Veterinary medicine, CEO, Guidance, Research, Documentation, Letter, Food, Veterinarian, Pharmacy, FDA, Compliance, Review, Patient, Pharmaceutical industry, Industry

The Guidance is slated to be enforced beginning October 1, 2022.

Key Points: 
  • The Guidance is slated to be enforced beginning October 1, 2022.
  • The survey reports on the responses of 1,574 veterinary professionals in the U.S, all of whom work in practices that prescribe compounded medications for animal health.
  • FDA's new Guidance will change the way medication is obtained by veterinary practices for difficult-to-treat patients, those whose needs cannot be met by FDA-approved alternatives.
  • The most current FDA lists of nominated, under review, approved, and not listed bulk pharmaceutical ingredients are published by FDA .

Torrid Announces Appointment of Tim O. Martin, DTC Veteran, as Chief Operating Officer and Chief Financial Officer and Updates Second Quarter Fiscal 2022 Guidance

Retrieved on: 
Wednesday, August 3, 2022
Women, Fashion, Consumer, Retail, Specialty, EBITDA, Failure, Accounting, Intellectual property, Interim, Private Securities Litigation Reform Act, Interim management, Security (finance), Annual report, Depreciation, COVID-19, Guitar Center, Coldwater Creek, Information technology, Software, Woman, Workforce, NYSE, Culture, Company, GAAP, Review, Forecasting, Budget, Disclosure, Communication, U.S. Securities and Exchange Commission, CURV, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Technology, Investment, Mission statement, Bank account, Social media, Information, Tailored Brands, Income, Advertising, Privacy, Adjustment, Terrorism, Environment, Management, Risk management, Bookkeeping, Guidance, Belk, Gymboree, Torrid

I also want to welcome Hyon Park who will be joining us as our Chief Technology Officer.

Key Points: 
  • I also want to welcome Hyon Park who will be joining us as our Chief Technology Officer.
  • Mr. Park joins as Chief Technology Officer from Belk, Inc. where he served as Executive Vice President, Chief Information Officer.
  • The Company will provide an update to its fiscal 2022 outlook when it reports second quarter fiscal 2022 results on Wednesday, September 7, 2022.
  • For example, all statements we make relating to our expected second quarter of fiscal 2022 performance are forward-looking statements.

Rocket Lab Supports Significant Milestone for DARPA and Space Development Agency on the Mandrake-2 Mission

Retrieved on: 
Thursday, July 14, 2022
Aerospace, Technology, Manufacturing, Air, Transport, Satellite, Software, Military, Government Technology, Defense, Contracts, Neutron, Rocket Lab, NASA, Program, Kennedy Space Center, Spacecraft, SDA, Electron, Control, Risk, KSC, Blackjack, OISL, CEO, DARPA, Human, Rocket, Time, ASI, GNC, Moon, Lab, Navigation, Synthetic rubber, Communications satellite, Photon, Mars, Guidance, Aerospace, Technology, Manufacturing, Air, Transport, Satellite, Software, Military, Government Technology, Defense, Contracts

Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, has supported a significant milestone for DARPA and the Space Development Agencys (SDA) Mandrake-2 mission.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, has supported a significant milestone for DARPA and the Space Development Agencys (SDA) Mandrake-2 mission.
  • Rocket Lab has played a leading role in the mission through its team at Advanced Solutions Inc. (ASI), a Colorado-based aerospace engineering firm delivering mission proven space software, mission simulation, and testing solutions.
  • Rocket Lab provided to the mission MAX Flight Software, Guidance, Navigation and Control (GNC) design and analysis, MAX Ground Data System, and mission operations.
  • Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success.

Progress Made on Ethical Recruitment at Summit of the Americas Roundtable

Retrieved on: 
Tuesday, June 28, 2022
Department, United States federal government continuity of operations, View, Guidance, Farm, International Labour Organization, Flag of Djibouti, Workforce, ILO, International development, Industry, United States Secretary of Homeland Security, History, Non-governmental organization, United, DHS, H-2, Federation, Leadership, USAID, Guatemalan, H-2A, Multimedia, Howard, Employment agency

The roundtable was a chance for industry stakeholders to get face time with officials from the US and Northern Triangle governments, and a forum to announce the "Guidance on Fair Recruitment Practices for Temporary Migrant Workers."

Key Points: 
  • The roundtable was a chance for industry stakeholders to get face time with officials from the US and Northern Triangle governments, and a forum to announce the "Guidance on Fair Recruitment Practices for Temporary Migrant Workers."
  • Martinez sees the release of the Guidance as progress on responsible recruiting.
  • It's been created in accordance with the International Labor Organization's (ILO) guiding principles, which CIERTO has built our recruitment model around.
  • CIERTO is one of North America's leading recruiters, dedicated to assisting employers with federal H-2 visa programs.

Avantax Planning Partners Recognizes Affiliate Accomplishments During Largest-ever National Conference

Retrieved on: 
Thursday, June 16, 2022
Maker, Solution, TDT, Company, Top, Elevate, Atwell, LLC, Leadership, RIA, LinkedIn, CP, NASDAQ, CPA, Year, BCOR, Guidance, Blucora, Risk management, Communication, Conference, Pella, GLOBE, Financial adviser, Public relations, Financial services, Facebook

As part of the annual awards night, the highest-performing Avantax affiliate partners were recognized as part of Presidents Club, whose winners demonstrate exemplary productivity, client service, communication, planning guidance, and are advocates of Avantax Planning Partners.

Key Points: 
  • As part of the annual awards night, the highest-performing Avantax affiliate partners were recognized as part of Presidents Club, whose winners demonstrate exemplary productivity, client service, communication, planning guidance, and are advocates of Avantax Planning Partners.
  • Harding Shymanski & Company won the Best Practices Firm award, which goes to an Avantax Planning Partners firm exhibiting a strong commitment to following Avantax Planning Partners strategies, along with consistent execution and accountability.
  • The Firm of the Year leads Avantax Planning Partners in productivity, client service, communication, planning guidance, and are truly advocates of Avantax.
  • Avantax Planning Partners is a national financial planning and wealth management firm that partners with CPA firms to combine and deliver holistic financial and tax-planning services to their clients.

New Real-World Evidence Shows Improvements in Outcomes and Reduction in Healthcare Costs with Guidance® UTI Precision Diagnostic Test Compared to Standard Urine Culture in Patients with Complicated Urinary Tract Infections

Retrieved on: 
Saturday, May 14, 2022
Diabetes, Medical Affairs Bureau, Risk, Urinary tract infection, Sex, Cutis, Infection, Multimedia, Cutis laxa, Patient, View, Health, Solution, Microbiology, Composite, Nature Reviews Microbiology, University Challenge 2013–14, UTI, Medicare Part D, Epidemiology, Medicare, Guidance, AUA, SNF, SUC, PCR, American Urological Association, SVP, Pyelonephritis, Diagnosis, Medical imaging, Pharmaceutical industry, Hospital

IRVINE, Calif., May 14, 2022 /PRNewswire/ -- Real-world evidence from a Medicare database analysis presented today at the 2022 American Urology Association (AUA) Meeting shows that Guidance UTI testing is associated with reductions in critical adverse outcomes, healthcare resource utilization and costs for complicated urinary tract infections (cUTIs) compared to standard urine culture (SUC). The comparative analysis was designed to examine outcomes of one year of cUTI treatment guided by either Guidance UTI or SUC.

Key Points: 
  • The findings reinforce the real-world benefits of Guidance UTI's increased sensitivity, reduced time to results, and P-AST results to patients, providers, and the healthcare system."
  • UTI-related clinical, healthcare use and costs outcomes were then tracked for one year.
  • Guidance UTI testing was associated with 44% lower total costs and 77% lower clinically-advanced costs* compared to SUC, and cUTIs in the Guidance UTI cohort were likelier to be managed successfully as outpatients.
  • The rate of outpatient emergency visits was 13% lower and inpatient admissions were 67% lower when using Guidance UTI compared to SUC.

DOVE® Dental Products introduces single-use hybrid device with aerosol management to combat the spread of COVID-19

Retrieved on: 
Wednesday, May 11, 2022
COVID-19, Guidance, Sterilization, Aerosol, AERO, Langeloh, Suction, Dental care, Safety, CDC, Patient, Center, Movement, Korea Disease Control and Prevention Agency, Infection, Nissin Dental Products, Inc., SE, Collection, Risk, Multimedia, Medical device, Dentistry, Injection moulding

CHESTERFIELD, Mo., May 11, 2022 /PRNewswire/ -- DOVE® Dental Products announces the release of the new DOVE® AERO, a single-use hybrid device designed to significantly reduce the risk of airborne aerosol movement caused by instrument use in a dental setting.

Key Points: 
  • CHESTERFIELD, Mo., May 11, 2022 /PRNewswire/ -- DOVE Dental Products announces the release of the new DOVE AERO, a single-use hybrid device designed to significantly reduce the risk of airborne aerosol movement caused by instrument use in a dental setting.
  • With the introduction of the new AERO product, DOVE Dental Products is leading the charge.
  • To date, no device on the market addresses all three concerns without sacrificing patient comfort or altering dental practices.
  • About DOVE Dental Products: DOVE Dental Products is dedicated to developing and distributing innovative, cost-effective disposable oral evacuation devices that prevent backflow and eliminate cross-contamination between patients.

China releases its first ESG disclosure standard with Ping An's participation

Retrieved on: 
Wednesday, May 11, 2022
Task force, Forbes Global 2000, Ecosystem, Carbon, Deccan Development Society, Health, Disclosure, Forbes, Insurance, Organization, Internet, Overalls, Environment, Industry, Fortune, Ping'an, Group, Fortune Global 500, Enterprise, Technology, ESG, Awareness, Risk management, Guidance

HONG KONG and SHANGHAI, May 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that it has helped to develop China's first ESG disclosure standard, the "Guidance for Enterprise ESG Disclosure", published by the China Enterprise Reform and Development Society (CERDS). The Guidance, effective on June 1, 2022, was developed with the participation of Ping An and dozens of other companies in China. 

Key Points: 
  • The Guidance, effective on June 1, 2022, was developed with the participation of Ping An and dozens of other companies in China.
  • The Guidance includes a corporate ESG disclosure indicator system with three dimensions environmental, social, and governance and provides a basic framework for ESG disclosure.
  • As a pioneer in ESG in China, Ping An participated in the drafting of the disclosure framework, sharing its practical experience in ESG.
  • The "Guidance for Enterprise ESG Disclosure" is an important milestone for Ping An to promote the development of an ESG system with Chinese characteristics.

China releases its first ESG disclosure standard with Ping An's participation

Retrieved on: 
Wednesday, May 11, 2022
Task force, Forbes Global 2000, Ecosystem, Carbon, Deccan Development Society, Health, Disclosure, Forbes, Insurance, Organization, Internet, Overalls, Environment, Industry, Fortune, Ping'an, Group, Fortune Global 500, Enterprise, Technology, ESG, Awareness, Risk management, Guidance

HONG KONG and SHANGHAI, May 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that it has helped to develop China's first ESG disclosure standard, the "Guidance for Enterprise ESG Disclosure", published by the China Enterprise Reform and Development Society (CERDS). The Guidance, effective on June 1, 2022, was developed with the participation of Ping An and dozens of other companies in China. 

Key Points: 
  • The Guidance, effective on June 1, 2022, was developed with the participation of Ping An and dozens of other companies in China.
  • The Guidance includes a corporate ESG disclosure indicator system with three dimensions environmental, social, and governance and provides a basic framework for ESG disclosure.
  • As a pioneer in ESG in China, Ping An participated in the drafting of the disclosure framework, sharing its practical experience in ESG.
  • The "Guidance for Enterprise ESG Disclosure" is an important milestone for Ping An to promote the development of an ESG system with Chinese characteristics.

Pathnostics to Present New Real-World Data Analysis of its Guidance® UTI Precision Diagnostic Test at the 2022 American Urology Association Annual Meeting

Retrieved on: 
Tuesday, May 10, 2022
Hospital, PGY, Brown University, AUA, Booth, Medicare, Guidance, Epidemiology, Urinary tract infection, Tuberculosis verrucosa cutis, PCR, Patient, Infection, American Urological Association, Health, View, Microbiology, Conference, Solution, UTI, Nature Reviews Microbiology, SUC, Sepsis, Multimedia, Medical imaging, Pharmaceutical industry, MD, Urology

IRVINE, Calif., May 10, 2022 /PRNewswire/ -- Pathnostics, a leading precision diagnostic testing and development company, today announced that it will present results of a Medicare database analysis designed to determine rates of adverse outcomes, medical resource utilization, and costs with Guidance UTI compared to standard urine culture (SUC) in patients with complicated urinary tract infections (cUTI). These results will be presented at the 2022 American Urology Association (AUA) Meeting, taking place from May 13-16, in New Orleans, Louisiana.

Key Points: 
  • These results will be presented at the 2022 American Urology Association (AUA) Meeting, taking place from May 13-16, in New Orleans, Louisiana.
  • Annually, UTIs contribute to 10.5 million office visits and carry a cost of approximately $3.5 billioni.
  • Guidance UTI is an advanced test that combines PCR and Pooled Antibiotic Susceptibility Testing (P-AST), which better address polymicrobial infections where bacterial interactions can impact antibiotic resistance.
  • Pathnostics is a leading precision diagnostic testing and development company providing solutions for infectious disease and cancer diagnostics that will get patients on the right path.